The Technical Analyst
Select Language :
Edap Tms SA [EDAP]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices

Edap Tms SA Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Edap Tms SA is listed at the  Exchange

3.52% €7.35

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 271.42 mill
EPS: -0.650
P/E: -11.31
Earnings Date: May 14, 2024
SharesOutstanding: 36.93 mill
Avg Daily Volume: 0.0396 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -11.31 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.05x
Company: PE -11.31 | industry: PE 222.16
DISCOUNTED CASH FLOW VALUE
€-4.86
(-166.11%) €-12.21
Date: 2024-03-29
Expected Trading Range (DAY)

€ 6.92 - 7.78

( +/- 5.81%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €7.30
Forecast 2: 16:00 - €7.30
Forecast 3: 16:00 - €7.30
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €7.35 (3.52% )
Volume 0.0584 mill
Avg. Vol. 0.0396 mill
% of Avg. Vol 147.66 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Edap Tms SA

Last 12 Months

Last 12 months chart data with high, low, open and close for Edap Tms SA

RSI

Intraday RSI14 chart for Edap Tms SA

Last 10 Buy & Sell Signals For EDAP

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:00buy€6.47N/AActive
Profile picture for
            Edap Tms SA

EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Last 10 Buy Signals

Date Signal @
XAUTUSDMar 29 - 07:19$2 232.78
POLYXUSDMar 29 - 07:190.529
VRXUSDMar 29 - 07:1862.71
TOMOUSDMar 29 - 07:13$1.061
POOLXUSDMar 29 - 07:095.22
COREUSDMar 29 - 07:086 994.98
PENDLEUSDMar 29 - 07:094.21
BFICUSDMar 29 - 07:079.89
RETH2USDMar 29 - 06:593 540.59
PUNDIXUSDMar 29 - 06:580.696

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.